Skip to content
Krypton AI
Client portal
  1. 1Your company
  2. 2Pick a time

Book 30 minutes with us.

Start with your ticker. We prepare a first read on your company before we meet, and a person reviews it.

Prefer email? contact@kryptonai.io

Inogen, Inc.

Ticker
INGN
Sector
Medical devices
Dated
Written 23 September 2026, published 29 September 2026
Stance
BUY (initiated)

Priced as a declining oxygen-device maker. US unit volume rose by high single digits last quarter while US sales fell, and net cash covers 75% of the market value.

Price (29 Sep 26)
$5.37
Price target (12m)
$8.90
Scenario value*
$9.05
Bear / Base / Bull
$3.81 / $8.94 / $14.54
Market cap
$142.5M
Enterprise value
$35.6M
Free float
87.5% of S/O
Avg daily vol, 3m
262k / $1.5M
Short interest
6.3% float
Institutional own.
72.3%, +2.9pt
Largest holder
Yuwell, 9.9%
Insider and board
2.5%

*Probability-weighted, 25/50/25, over 12 to 24 months. Price target is the base case, rounded to the nearest ten cents.

The thesis

  1. An industry buyer paid about twice today's price. Yuwell, a Chinese respiratory-device maker, paid $10.36 a share for 9.9% in early 2025 and has not reduced the stake, and the company bought back 1.1M shares in H1 2026 at $6.55.
  2. The board changed. Kent Lake's April 2026 cooperation agreement added Vafa Jamali, who sold ZimVie at a 99% premium to its 90-day average price, and his impact has not reached reported results yet.
  3. The US decline is a channel shift, not lost demand. US direct-to-consumer sales fell from $96.0m in 2023 to $61.9m in 2025 while wholesale sales rose from $66.2m to $94.6m, and Q2 2026 unit volume grew.
  4. The balance sheet gives the turnaround a runway. Net cash of $106.8m against a $143m market cap, no debt and $22.5m left on the buyback limit the downside.

The full report

6 pages, 693 KB, free with the LALC newsletter.

Inogen, Inc.

The full report is free with LALC, our research newsletter. Confirm your address from the email we send, and the report is on the page that opens. One click to leave.

Leave a comment

Comments are read before they appear.